Amgen (AMGN) To Host Conference Call To Discuss New Topline Data In Inflammation And Rare Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. USO
8. IBM
9. HOOD
10. ABBV

Go back to Amgen (AMGN) To Host Conference Call To Discuss New Topline Data In Inflammation And Rare Disease

Truist Securities Reiterates Buy Rating on Amgen (AMGN)

September 25, 2024 5:43 AM EDT

Truist Securities analyst Robyn Karnauskas reiterated a Buy rating and $320.00 price target on Amgen (NASDAQ: AMGN).

The analyst comments "Earlier this evening, Amgen (AMGN, Buy) provided positive Ph3 updates from two key pipeline programs - Uplizna in gMG and rocatinlimab in atopic... More